Back to Search
CANAN TURAL, M.D.
M.D.
Pediatrics Physician
NPI: 1063460772Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
216097(MA)MD13487(RI)
Research & Publications (20)
Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.
PMID 19171202·Clin Gastroenterol Hepatol·2009
8-other
Differences in virological response to pegylated interferon and ribavirin between hepatitis C virus (HCV)-monoinfected and HCV-HIV-coinfected patients.
PMID 19195330·Antivir Ther·2008
8-other
Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study.
PMID 17875005·J Viral Hepat·2007
4-observational
Management of HIV/hepatitis C virus-coinfected patient non-responders to hepatitis C virus antiviral therapy and relapsers.
PMID 19372933·Curr Opin HIV AIDS·2007
8-other
Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients.
PMID 12614468·J Viral Hepat·2003
8-other
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
PMID 11807305·AIDS·2002
3-trial
Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
PMID 19200132·J Viral Hepat·2009
8-other
Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients.
PMID 19085908·Hepatology·2009
4-observational
Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection.
PMID 19215579·J Viral Hepat·2009
6-review
Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality.
PMID 19275591·Curr HIV Res·2009
8-other
Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.
PMID 19363085·J Antimicrob Chemother·2009
3-trial
Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
PMID 19575364·Hepatology·2009
8-other
Recently acquired HIV infection in Spain (2003-2005): introduction of the serological testing algorithm for recent HIV seroconversion.
PMID 18987013·Sex Transm Infect·2009
4-observational
Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
PMID 18097222·AIDS·2008
4-observational
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
PMID 18257771·HIV Med·2008
6-review
Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain).
PMID 18297762·J Acquir Immune Defic Syndr·2008
8-other
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone.
PMID 18854330·J Antimicrob Chemother·2008
3-trial
The magnitude of interferon-gamma responses to human cytomegalovirus is predictive for HIV-1 disease progression.
PMID 18989229·J Acquir Immune Defic Syndr·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 154 WATERMAN ST
PROVIDENCE, RI 02906 - Phone
- (401) 383-4411
Quick Facts
- NPI
- 1063460772
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile